Autoinflammatory syndromes are caused by an exaggerated innate immune system response and can pose important diagnostic challenges. They are often diagnosed by a combination of clinical findings and genetic testing. First presentation is often in childhood, although 10% of patients develop their first symptoms after the age of 30 1 .
Herein we report a complex case with heterozygosity for MEFV with atypical Adult Onset Still's Disease (AOSD) in a 39-year-old Colombian woman, in her 3rd pregnancy trimester. At 33 weeks gestation, she presented with a sore throat, polyarthralgia, myalgia and pleuritic chest pains. She had an erythematous maculopapular rash thought to be pregnancy-related pruritic eruption. Earlier in pregnancy she had developed biopsy-confirmed reactive axillary lymphadenopathy. Past surgery included breast augmentation and bariatric surgery; family history unremarkable. Clinically she was tachycardic with wrist, metacarpophalangeal and proximal interphalangeal joint synovitis. She had bilateral pitting leg oedema which gradually spread to the abdomen, associated with worsening hypoalbuminaemia.
Inflammatory markers were raised; CRP 102mg/L, ESR60 mm/hr; white cell differential, ANA, ANCA, rheumatoid factor/anti-CCP and complement levels were all normal. Chest Xray showed unilateral consolidation. She was commenced on prednisolone for suspected reactive arthritis with broad spectrum antibiotic cover. After a brief clinical improvement, she deteriorated, continuing to remain afebrile. Emergency caesarean section was performed at 34 weeks due to concerns over maternofetal wellbeing.
On day 3 post caesarean section she became febrile with worsening chest and joint pain. Abdominopelvic and chest CT and echocardiograph were normal. Colchicine was trialed unsuccessfully. Antibiotics were withdrawn after persistently negative microbiology tests with fever settling on day 6. She continued to deteriorate clinically with myalgia, arthralgia, abdominal and pleuritic chest pains. At this point, the possibility of an autoinflammatory syndrome +/-atypical AOSD was considered due to a raised ferritin (5154 μg/L) and CRP (300mg/L). After multidisciplinary discussion, intravenous methylprednisolone 1g/d was commenced for 3 days, along with intravenous immunoglobulins for 5 days. This regimen was successful with a dramatic improvement in her inflammatory markers ( Figure 1 ) and clinical picture. Further investigations revealed raised serum amyloid A (703mg/L) and genetic testing confirmed the presence of MEFV I591T.The patient was discharged home and remains stable at 1-year follow-up on colchicine, azathioprine, and hydroxychloroquine.
FMF is the most common autoinflammatory syndrome resulting from mutations in the MEFV gene that encodes the protein pyrin which is involved in the regulation of inflammation and apoptosis; mutations lead to inflammation characterised by excessive Interleukin (IL)-1 secretion 2 . Initially, five mutations (V726A, M694V, M694I, M680I and E148Q) were identified which account for 74% of all cases 3 .
However, a number of other mutations have since been identified with their significance often unknown. Rare mutations are preferentially found in populations not normally associated with the disease. This includes I591T on exon 9, described in a patient from France 3 , and a Spanish family 4 and associated with FMF both in conjunction with a second mutation and as the sole genetic abnormality. One hypothesis, for other MEFV genes being identified is that they may be involved in non-FMF conditions 5 .
Incidence is highest in populations around the Mediterranean but there are reported cases in Asia and South America. Classically, patients experience recurrent self-limiting episodes of fever and serositis. Pleural involvement occurs in 15% and is usually unilateral 2 . The trigger to these events can be physical/emotional stress resulting in an intense acute phase reaction 2 . Use of IL-1 receptor antagonists shows promise in patients who are intolerant to colchicine. AA amyloidosis and renal failure are serious complications if untreated.
AOSD is also considered an autoinflammatory disorder. Diagnosis is made clinically and relies on the classical triad of daily spiking fevers, polyarthritis and a salmon-pink evanescent rash. Other manifestations include a prodromal sore throat, myalgia, weight loss, serositis, lymphadenopathy, hepatomegaly and macrophage activation syndrome. Laboratory findings include raised inflammatory markers, normocytic anaemia, hypoalbuminaemia, and raised serum ferritin in 50% of cases. FMF-related MEFV variants are implicated with the disease phenotype of AOSD 6 .
This case is an example of a challenging autoinflammatory syndrome occurring in pregnancy in a patient of Hispanic ethnicity, heterozygote for an MEFV mutation and with no family history. Her clinical disease was not diagnostic of either FMF by the Tel-Hashomer criteria 7 nor AOSD. Nonetheless some of the clinical/biochemical manifestations, particularly the high ferritin are much more consistent with AOSD than FMF. She responded well to methylprednisolone and has been well as an outpatient on broad spectrum immunosuppression and colchicine. Colchicine is very effective prophylaxis in FMF and has been reported to be beneficial in patients with disease associated with heterozygous carriage of MEVF I591T 8 . Furthermore, a Japanese study suggested that MEFV variants (excluding the very common polymorphism E148Q) are over-represented in ASOD and are associated with recurrent or severe inflammation and an increased requirement for biologics 6 . We hope that prophylactic colchicine will ameliorate any pro-inflammatory contribution from the variant pyrin. This case highlights the diagnostic dilemmas that can be associated with adult-onset autoinflammatory syndromes, as well as the importance of multi-disciplinary team input and coordinated care. Further exploration of MEFV I591T is required to evaluate its contribution to this patient's auto-inflammatory disease. 
